Gastric Mucosa-Associated Lymphoid Tissue Lymphoma

Adam, Birgit; Pech, Oliver; Steckstor, M; Tannapfel, Andrea; Riphaus, A.

doi:10.1016/s2212-0971(13)70072-4

Cited by 1 publication

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Chronic H. pylori infection is thought to promote clonal expansion of gastric lymphocytes, leading to gastric lymphoma. Approximately 40–50% of cases are gastric marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) and 20–40% are extra-nodal lymphomas [ 5 ].…”

Section: Introductionmentioning

confidence: 99%

Epidemiology, Diagnosis, Staging and Multimodal Therapy of Esophageal and Gastric Tumors

Cummings

Wong

Palm

et al. 2021

Cancers

View full text Add to dashboard Cite

Gastric and esophageal tumors are diverse neoplasms that involve mucosal and submucosal tissue layers and include squamous cell carcinomas, adenocarcinomas, spindle cell neoplasms, neuroendocrine tumors, marginal B cell lymphomas, along with less common tumors. The worldwide burden of esophageal and gastric malignancies is significant, with esophageal and gastric cancer representing the ninth and fifth most common cancers, respectively. The approach to diagnosis and staging of these lesions is multimodal and includes a combination of gastrointestinal endoscopy, endoscopic ultrasound, and cross-sectional imaging. Likewise, therapy is multidisciplinary and combines therapeutic endoscopy, surgery, radiotherapy, and systemic chemotherapeutic tools. Future directions for diagnosis of esophageal and gastric malignancies are evolving rapidly and will involve advances in endoscopic and endosonographic techniques including tethered capsules, optical coherence tomography, along with targeted cytologic and serological analyses.

show abstract

Section: Introductionmentioning

confidence: 99%